Literature DB >> 6379396

Is cancer communicable?

H T Lynch, G S Schuelke, M K O'Hara.   

Abstract

Recent developments in cancer epidemiology have led to the possibility of an exceedingly complex communicable factor(s) in cancer etiology. The transmission of such an agent(s) may require a susceptible genotype and/or other promotional events. Likely candidates which support this supposition include: Epstein-Barr virus (nasopharyngeal carcinoma, Burkitt's lymphoma, salivary gland tumor among Eskimos, X-linked lymphoproliferative syndrome of Purtilo); human T-cell leukemia virus (adult T-cell leukemia); acquired immune deficiency syndrome (AIDS), complicated by Kaposi's sarcoma (etiologic agent remains elusive, though epidemiology suggests possible infectious transmission); abnormal immune phenomena in households of Hodgkin's disease patients; and clustering of various types of cancer in spouses, the general population, and families. We have selectively reviewed the literature and evolved an etiologic hypothesis which integrates a communicable agent(s) in concert with genetic and/or environmental carcinogenic interaction which could conceivably explain a significant fraction of the total cancer burden.

Entities:  

Mesh:

Year:  1984        PMID: 6379396     DOI: 10.1016/0306-9877(84)90054-9

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN: 0306-9877            Impact factor:   1.538


  2 in total

1.  Childhood brain tumor: presentation at younger age is associated with a family tumor history.

Authors:  A Sussman; A Leviton; E N Allred; C Aschenbrener; D F Austin; F H Gilles; E T Hedley-Whyte; L N Kolonel; J L Lyon; G M Swanson
Journal:  Cancer Causes Control       Date:  1990-07       Impact factor: 2.506

2.  Mouse mammary tumor virus (MMTV)-like DNA sequences in the breast tumors of father, mother, and daughter.

Authors:  Polly R Etkind; Alexandre Fr Stewart; Peter H Wiernik
Journal:  Infect Agent Cancer       Date:  2008-02-28       Impact factor: 2.965

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.